000 01375 a2200373 4500
005 20250517022449.0
264 0 _c20160314
008 201603s 0 0 eng d
022 _a1759-5053
024 7 _a10.1038/nrgastro.2015.36
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCunningham, Evan B
245 0 0 _aMixed HCV infection and reinfection in people who inject drugs--impact on therapy.
_h[electronic resource]
260 _bNature reviews. Gastroenterology & hepatology
_cApr 2015
300 _a218-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCoinfection
_xdrug therapy
650 0 4 _aGlobal Health
_xstatistics & numerical data
650 0 4 _aHepatitis C
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferons
_xtherapeutic use
650 0 4 _aPrevalence
650 0 4 _aRecurrence
650 0 4 _aRisk Factors
650 0 4 _aSubstance Abuse, Intravenous
_xepidemiology
650 0 4 _aTreatment Outcome
700 1 _aApplegate, Tanya L
700 1 _aLloyd, Andrew R
700 1 _aDore, Gregory J
700 1 _aGrebely, Jason
773 0 _tNature reviews. Gastroenterology & hepatology
_gvol. 12
_gno. 4
_gp. 218-30
856 4 0 _uhttps://doi.org/10.1038/nrgastro.2015.36
_zAvailable from publisher's website
999 _c24717027
_d24717027